Back to company

Compact Biomedical ApS: Financial statements 2024

CVR: 32780601

Compact Biomedical ApS (CVR 32780601) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -10,952 and a net result of DKK -36,656 compared with DKK 3,164,180 the year before. Equity amounted to DKK -129,718.

Gross Profit
-10,952 kr.
Profit/Loss
-36,656 kr.
Equity
-129,718 kr.
Total Assets
5,475 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--11 t.-37 t.-130 t.0
2023--31 t.3.2 mio.-93 t.-
2022--8 t.-1.9 mio.-3.3 mio.-
2021--7 t.-1.9 mio.-1.4 mio.-
2020--6 t.-4.3 mio.519 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Compact Biomedical ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Compact Biomedical ApS: The 2023 annual report is outMay 2, 2024

Compact Biomedical ApS has published its annual report for 2023. Gross profit came to DKK -31,019, and the net result was DKK 3,164,180.

About Compact Biomedical ApS

Compact Biomedical ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Sten Velschow. The company is owned by Sten Velschow. In 2025, the company reported a gross profit of DKK 60,971 and a net result of DKK 48,494 compared with DKK -36,656 the year before. Equity amounted to DKK -81,224.